| Dr William Thomas Bennett, DO | |
|
211 Park St, Attleboro, MA 02703-3137 | |
| (508) 222-5200 | |
| (508) 236-7043 |
| Full Name | Dr William Thomas Bennett |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 211 Park St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528041365 | NPI | - | NPPES |
| S400429510 | Other | MA | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 234083 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Medical Center | Brockton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Emergency Physicians Inc | 0244401404 | 148 |
News Archive
When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher at Robarts Research Institute at The University of Western Ontario has identified a protein that regulates apoptosis, a new discovery which has implications for both the diagnosis and treatment of cancer. Caroline Schild-Poulter's findings are now published online in the journal Molecular Cancer Research.
The staff at Medical Accounts Systems and the attorneys at Jorge M. Abril, P.A. are pleased to announce the launch of Healthcare Provider Payment, a blog dedicated to helping healthcare professionals and other interested parties stay abreast of relevant news and emerging trends in healthcare reimbursement, from insurance litigation news and Managed Care contracting issues, to health law and policy in general.
Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound - delta-12-protaglandin J3, or D12-PGJ3 - targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice, said Sandeep Prabhu, associate professor of immunology and molecular toxicology in the Department of Veterinary and Medical Sciences.
› Verified 6 days ago
| Entity Name | Steward Emergency Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780971275 PECOS PAC ID: 0244401404 Enrollment ID: O20110919000768 |
News Archive
When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher at Robarts Research Institute at The University of Western Ontario has identified a protein that regulates apoptosis, a new discovery which has implications for both the diagnosis and treatment of cancer. Caroline Schild-Poulter's findings are now published online in the journal Molecular Cancer Research.
The staff at Medical Accounts Systems and the attorneys at Jorge M. Abril, P.A. are pleased to announce the launch of Healthcare Provider Payment, a blog dedicated to helping healthcare professionals and other interested parties stay abreast of relevant news and emerging trends in healthcare reimbursement, from insurance litigation news and Managed Care contracting issues, to health law and policy in general.
Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound - delta-12-protaglandin J3, or D12-PGJ3 - targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice, said Sandeep Prabhu, associate professor of immunology and molecular toxicology in the Department of Veterinary and Medical Sciences.
› Verified 6 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255600300 PECOS PAC ID: 2860688728 Enrollment ID: O20120430000164 |
News Archive
When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher at Robarts Research Institute at The University of Western Ontario has identified a protein that regulates apoptosis, a new discovery which has implications for both the diagnosis and treatment of cancer. Caroline Schild-Poulter's findings are now published online in the journal Molecular Cancer Research.
The staff at Medical Accounts Systems and the attorneys at Jorge M. Abril, P.A. are pleased to announce the launch of Healthcare Provider Payment, a blog dedicated to helping healthcare professionals and other interested parties stay abreast of relevant news and emerging trends in healthcare reimbursement, from insurance litigation news and Managed Care contracting issues, to health law and policy in general.
Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound - delta-12-protaglandin J3, or D12-PGJ3 - targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice, said Sandeep Prabhu, associate professor of immunology and molecular toxicology in the Department of Veterinary and Medical Sciences.
› Verified 6 days ago
| Entity Name | South Shore Health Express Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477044212 PECOS PAC ID: 6406108836 Enrollment ID: O20181115000152 |
News Archive
When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher at Robarts Research Institute at The University of Western Ontario has identified a protein that regulates apoptosis, a new discovery which has implications for both the diagnosis and treatment of cancer. Caroline Schild-Poulter's findings are now published online in the journal Molecular Cancer Research.
The staff at Medical Accounts Systems and the attorneys at Jorge M. Abril, P.A. are pleased to announce the launch of Healthcare Provider Payment, a blog dedicated to helping healthcare professionals and other interested parties stay abreast of relevant news and emerging trends in healthcare reimbursement, from insurance litigation news and Managed Care contracting issues, to health law and policy in general.
Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound - delta-12-protaglandin J3, or D12-PGJ3 - targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice, said Sandeep Prabhu, associate professor of immunology and molecular toxicology in the Department of Veterinary and Medical Sciences.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Thomas Bennett, DO 21 Whites Hill Dr, Braintree, MA 02184-6041 Ph: (917) 453-6316 | Dr William Thomas Bennett, DO 211 Park St, Attleboro, MA 02703-3137 Ph: (508) 222-5200 |
News Archive
When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher at Robarts Research Institute at The University of Western Ontario has identified a protein that regulates apoptosis, a new discovery which has implications for both the diagnosis and treatment of cancer. Caroline Schild-Poulter's findings are now published online in the journal Molecular Cancer Research.
The staff at Medical Accounts Systems and the attorneys at Jorge M. Abril, P.A. are pleased to announce the launch of Healthcare Provider Payment, a blog dedicated to helping healthcare professionals and other interested parties stay abreast of relevant news and emerging trends in healthcare reimbursement, from insurance litigation news and Managed Care contracting issues, to health law and policy in general.
Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.
Women who stopped taking the postmenopausal hormone combination of estrogen plus progestin experienced a marked decline in breast cancer risk which was unrelated to mammography utilization change, according to a study from the Women's Health Initiative led by a Los Angeles Biomedical Research Institute (LA BioMed) investigator that was published today in The New England Journal of Medicine.
A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound - delta-12-protaglandin J3, or D12-PGJ3 - targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice, said Sandeep Prabhu, associate professor of immunology and molecular toxicology in the Department of Veterinary and Medical Sciences.
› Verified 6 days ago
Hung Q Nguyen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7020 | |
Dr. Mark M Mcguire, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Sturdy Memorial Hospital, 211 Park St., Attleboro, MA 02703 Phone: 508-236-7020 | |
Ronald Van Ness-otunnu, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-222-5200 | |
Dr. Michael Demelis, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Park Street, Attleboro, MA 02703 Phone: 508-236-7020 | |
Dr. Brian Bhupendra Patel, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7040 | |
Dr. Brian J Kelly, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-236-7046 |